The SNAP Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Neuropathic Post-Amputation Pain

Status:	Recruiting
Conditions:	Neurology
Therapuetic Areas:	Neurology
Healthy:	No
Age Range:	21 - Any
Updated:	3/3/2019
Start Date:	December 18, 2018
End Date:	October 2022

The SNAP Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Neuropathic Post-Amputation Pain in a Randomized, Double-blinded, Placebo-controlled, Multicenter Trial

The purpose of this study is to determine if pain can be relieved by delivering small amounts
of electricity (called "electrical stimulation") to the nerves in an individual's amputated
leg.This study will involve the use of a Peripheral Nerve Stimulation (PNS) System that is
made by SPR Therapeutics (the sponsor of the study). The PNS System was cleared by the FDA
for up to 60 days of use for the management of chronic pain, including extremity (leg) pain.

Key Inclusion Criteria:

- At least 21 years old

- Lower extremity amputation

- Experiencing residual limb (stump) and/or phantom limb pain

- Healed amputation and healthy residual limb based upon the investigator's evaluation

Key Exclusion Criteria:

- Conditions with increased risk of infection (e.g., compromised immune system or
history of recurrent skin infections)

- Implanted electronic device

- Pregnancy

We found this trial at

sites

The University of California, San Diego

9500 Gilman Dr
La Jolla, California 92093

(858) 534-2230